Both in Pharmaceuticals
Geron vs Zevra Therapeutics
Over the past year GERN returned −27.9% and ZVRA returned +1.4%; their daily moves had a correlation of 0.17.
GERN −27.9% ZVRA +1.4%Growth of $1, one year, split-adjusted
| Metric | GERN | ZVRA |
|---|---|---|
| Price | $0.8944 | $10.28 |
| Market cap | $574.6M | $610.5M |
| Today | −5.47% | −0.77% |
| 1 month | −26.1% | +1.0% |
| 6 months | −43.4% | +2.1% |
| Year to date | −32.2% | +14.7% |
| 1 year | −27.3% | +1.6% |
| Revenue growth (YoY) | +17.2% | +53.3% |
| Gross margin | 83.9% | 96.2% |
| Net margin | −29.0% | 21.2% |
| P/E (TTM) | — | 10.5× |
| Price / sales | 2.8× | 4.5× |
| Net cash | $51.1M | $221.6M |
| Dividend yield | — | — |
| Volatility (60d) | 60.1% | 44.3% |
| Short % of float | 11.9% | 10.8% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).